Request Deal Involvement

Novo led a $112m Series B round in AvenCell.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ropes & Gray

legal advisors

Ropes & Gray

or

Principals

NYBC VENTURES

bidder

NYBC VENTURES

AVENCELL THERAPEUTICS

target

AVENCELL THERAPEUTICS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

BLACKSTONE LIFE SCIENCES

bidder

BLACKSTONE LIFE SCIENCES

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

EIGHT ROADS VENTURES

bidder

EIGHT ROADS VENTURES

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo led a $112m Series B round in AvenCell.